Expression of Bcl-2 and microRNAs in cardiac tissues of patients with dilated cardiomyopathy

Wang,Yong; Li,Min; Xu,Li; Liu,Ju; Wang,Dong; Li,Quan; Wang,Lili; Li,Peijie; Chen,Shanliang; Liu,Tianqi

doi:10.3892/mmr.2016.5977

Expression of Bcl-2 and microRNAs in cardiac tissues of patients with dilated cardiomyopathy

Authors:
- Yong Wang
- Min Li
- Li Xu
- Ju Liu
- Dong Wang
- Quan Li
- Lili Wang
- Peijie Li
- Shanliang Chen
- Tianqi Liu
View Affiliations

Affiliations: Department of Cardiovascular Surgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China, Weifang Medical College, Weifang, Shandong 261031, P.R. China
Published online on: December 2, 2016 https://doi.org/10.3892/mmr.2016.5977
Pages: 359-365

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dilated cardiomyopathy (DCM) is associated with sudden cardiac death and heart failure, resulting in a significant medical burden. The mechanisms underlying the pathogenesis of DCM remain elusive. In the present study, human cardiac tissues from patients with DCM and healthy donors were collected and their pathology was examined. The expression levels of apoptosis regulator Bcl-2 and fibrosis-associated microRNAs were also evaluated. Extensive myocardial fibrosis and apoptosis in DCM cardiac tissues was observed. As demonstrated by western blotting, reverse transcription-quantitative polymerase chain reaction and immunohistochemistry, the expression of Bcl‑2 was significantly increased in the apex, and the left and right ventricle of the heart in patients with DCM. In the specified locations, it was identified that miR‑21 was upregulated, while members of miR‑29 family (miR‑29a, miR‑29b and miR‑29c) and miR‑133 family (miR-133a and miR-133b) were downregulated. The present study suggested that Bcl‑2 and specific microRNAs may be involved in DCM pathogenesis, with a potential implication as therapeutic targets.

View Figures

View References

1	Burkett EL and Hershberger RE: Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 45:969–981. 2005. View Article : Google Scholar : PubMed/NCBI
2	Jefferies JL and Towbin JA: Dilated cardiomyopathy. Lancet. 375:752–762. 2010. View Article : Google Scholar : PubMed/NCBI
3	Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL and Kasper EK: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342:1077–1084. 2000. View Article : Google Scholar : PubMed/NCBI
4	Isner JM, Kearney M, Bortman S and Passeri J: Apoptosis in human atherosclerosis and restenosis. Circulation. 91:2703–2711. 1995. View Article : Google Scholar : PubMed/NCBI
5	Weber KT, Brilla CG and Janicki JS: Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res. 27:341–348. 1993. View Article : Google Scholar : PubMed/NCBI
6	Frangogiannis NG, Smith CW and Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res. 53:31–47. 2002. View Article : Google Scholar : PubMed/NCBI
7	Agocha A, Lee HW and Eghbali-Webb M: Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: Effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor. J Mol Cell Cardiol. 29:2233–2244. 1997. View Article : Google Scholar : PubMed/NCBI
8	Di Napoli P, Taccardi AA, Grilli A, Felaco M, Balbone A, Angelucci D, Gallina S, Calafiore AM, De Caterina R and Barsotti A: Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy. Am Heart J. 146:1105–1111. 2003. View Article : Google Scholar : PubMed/NCBI
9	Tsipis A, Athanassiadou AM, Athanassiadou P, Kavantzas N, Agrogiannis G and Patsouris E: Apoptosis-related factors p53, bcl-2 and the defects of force transmission in dilated cardiomyopathy. Pathol Res Pract. 206:625–630. 2010. View Article : Google Scholar : PubMed/NCBI
10	Cleary ML and Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA. 82:7439–7443. 1985. View Article : Google Scholar : PubMed/NCBI
11	Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L and Wang HG: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA. 91:9238–9242. 1994. View Article : Google Scholar : PubMed/NCBI
12	Oltvai ZN and Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell. 79:189–192. 1994. View Article : Google Scholar : PubMed/NCBI
13	Yin XM, Oltvai ZN and Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:321–323. 1994. View Article : Google Scholar : PubMed/NCBI
14	Chen SJ, Wang JL, Chen JH and Huang RN: Possible involvement of glutathione and p53 in trichloroethylene- and perchloroethylene-induced lipid peroxidation and apoptosis in human lung cancer cells. Free Radic Biol Med. 33:464–472. 2002. View Article : Google Scholar : PubMed/NCBI
15	Latif N, Khan MA, Birks E, O'Farrell A, Westbrook J, Dunn MJ and Yacoub MH: Upregulation of the Bcl-2 family of proteins in end stage heart failure. J Am Coll Cardiol. 35:1769–1777. 2000. View Article : Google Scholar : PubMed/NCBI
16	Voinnet O: RNA silencing: Small RNAs as ubiquitous regulators of gene expression. Curr Opin Plant Biol. 5:444–451. 2002. View Article : Google Scholar : PubMed/NCBI
17	Hammond SM: Dicing and slicing: The core machinery of the RNA interference pathway. FEBS Lett. 579:5822–5829. 2005. View Article : Google Scholar : PubMed/NCBI
18	Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B and Pu WT: Altered microRNA expression in human heart disease. Physiol Genomics. 31:367–373. 2007. View Article : Google Scholar : PubMed/NCBI
19	Nair N, Kumar S, Gongora E and Gupta S: Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem. 376:33–40. 2013. View Article : Google Scholar : PubMed/NCBI
20	Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z and Wang Z: microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol. 7:565–574. 2014.PubMed/NCBI
21	Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al: Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation. 93:841–842. 1996. View Article : Google Scholar : PubMed/NCBI
22	Zhang WB, Du QJ, Li H, Sun AJ, Qiu ZH, Wu CN, Zhao G, Gong H, Hu K, Zou YZ and Ge JB: The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats. J Cell Mol Med. 16:2227–2237. 2012. View Article : Google Scholar : PubMed/NCBI
23	Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L and Koch G: Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 28:1781–1788. 1996. View Article : Google Scholar : PubMed/NCBI
24	Han Y, Peters DC, Dokhan B and Manning WJ: Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy. J Magn Reson Imaging. 30:967–972. 2009. View Article : Google Scholar : PubMed/NCBI
25	Unverferth DV, Baker PB, Swift SE, Chaffee R, Fetters JK, Uretsky BF, Thompson ME and Leier CV: Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 57:816–820. 1986. View Article : Google Scholar : PubMed/NCBI
26	Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M and Voipio-Pulkki LM: Apoptosis in human acute myocardial infarction. Circulation. 95:320–323. 1997. View Article : Google Scholar : PubMed/NCBI
27	Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M and Fontaine G: Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 335:1190–1196. 1996. View Article : Google Scholar : PubMed/NCBI
28	Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
29	Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, et al: Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:370–372. 1997. View Article : Google Scholar : PubMed/NCBI
30	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
31	Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008. View Article : Google Scholar : PubMed/NCBI
32	Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
33	van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
34	Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y and Yang B: Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 83:465–472. 2009. View Article : Google Scholar : PubMed/NCBI
35	Engelhardt S, Hein L, Wiesmann F and Lohse MJ: Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA. 96:7059–7064. 1999. View Article : Google Scholar : PubMed/NCBI
36	Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, et al: Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 32:817–830. 2000. View Article : Google Scholar : PubMed/NCBI